WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) today released the following statement on the anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act being signed into law:
“One year ago today, President Trump signed the SUPPORT for Patients and Communities Act into law to give relief to communities… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), top Republican on the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, and Congressman Greg Walden (OR-02), top Republican for the full committee, and Dr. Michael Burgess (TX-26), top Republican on the Health Subcommittee, are requesting information from the public about treatment for opioid use… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), top Republican on the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigation, this week led a hearing on the recent e-cigarette illness outbreak.
“I am deeply concerned about the ongoing outbreak of lung illness associated with vaping and e-cigarette use, as well as the marketing of e-cigarettes to kids,”… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), along with Congressman Eliot L. Engel (D-NY-16), led a group of 92 bipartisan lawmakers in a letter today to the Acting Commissioner of the Food and Drug Administration (FDA) Norman “Ned” Sharpless on the urgent issue of medical drug shortages.
The United States has recently faced shortages of vital drugs and medications, and the… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), top Republican on the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, this week spoke on the House floor to mark Opioid Crisis Awareness Week.
“My home state of Kentucky has been one of the hardest hit by our nation’s ongoing opioid crisis,” said Guthrie. “Sadly, over 1,300 Kentuckians died of a… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie’s (KY-02) bill to help certain Medicaid beneficiaries receive care in their homes was signed into law by President Donald Trump last week.
Guthrie introduced the EMPOWER Care Act with Congresswoman Debbie Dingell (D-MI) earlier this year to extend the Medicaid Money Follows the Person (MFP) program, which allows certain Medicaid beneficiaries,… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Republican leader of the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, today led a hearing on the illicit fentanyl trade and how it is impacting the nation’s ongoing opioid crisis.
“Fentanyl is a synthetic opioid that is 80 to 100 times stronger than morphine and 50 times more potent than heroin,”… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) supported multiple pieces of public health legislation at a House Energy and Commerce Committee Health Subcommittee markup yesterday.
The bipartisan No Surprises Act (H.R. 3630) will end the practice of surprise medical billing by ensuring that patients are held harmless and protected from surprise medical bills.
“Too often,… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), along with U.S. Reps. Diana DeGette (D-CO), Bob Latta (R-OH), Debbie Dingell (D-MI), introduced legislation this week to make more over-the-counter medications available to patients.
The legislation would reform the system that the U.S. Food and Drug Administration currently uses to review and approve new over-the-counter drugs for… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) joined Mario Anderson on “In Focus Kentucky” this weekend to discuss his latest work on health care.
In his role as the top Republican on the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, Guthrie has led investigations into rising insulin prices and the ongoing measles crisis. He also introduced… Read more »
